The latest information gathered on the involvement of the HPA axis and more recently on glutamate, opioids, cannabinoids, oxytocin, neuropeptide Y, and microRNA would suggest novel targets for future medications for PTSD that will be discussed below. The gene discussed is OXT; the disease is post-traumatic stress disorder.